JIANG Xin,XIN Ying,LUO Jing-hua,CHANG Peng-yu,FENG Qi,QU Ya-qin.Therapeutic effects of gensenoside-Rg3 combined with radiotherapy on advanced non-small cell lung cancer[J].Chinese Journal of Radiological Medicine and Protection,2012,32(2):196-198
Therapeutic effects of gensenoside-Rg3 combined with radiotherapy on advanced non-small cell lung cancer
Received:July 07, 2011  
DOI:10.3760/cma.j.issn.0254-5098.2012.02.022
KeyWords:Gensenoside-Rg3|Radiotherapy|Non-small cell lung cancer
FundProject:吉林省科技厅基金(200705221);吉林省发展与改革委员会基金(2010019-1)
Author NameAffiliationE-mail
JIANG Xin 130021 长春,吉林大学第一医院肿瘤中心放疗科  
XIN Ying 吉林大学病理生物学教育部重点实验室  
LUO Jing-hua 130021 长春,吉林大学第一医院肿瘤中心放疗科  
CHANG Peng-yu 130021 长春,吉林大学第一医院肿瘤中心放疗科  
FENG Qi 吉林大学第二医院放疗科  
QU Ya-qin Department of Radiotherapy, Cancer Center, First Hospital of Jilin University, Changchun 130021, China quyaqin52@163.com 
Hits: 3428
Download times: 2466
Abstract::
      Objective To study the efficacy and toxicity of gensenoside-Rg3 (Rg3) combined with radiotherapy on non-small cell lung cancer (NSCLC) at advanced stages (Ⅲ and Ⅳ). Methods Sixty-three patients with stage Ⅲ or ⅣNSCLC were divided randomly into two groups: treatment group (n=35) treated with Rg3 combined with radiotherapy and control group (n=28) treated with radiotherapy alone.The efficacy and side effects were compared after the treatment. Results The response rate (CR+PR) of the treatment group was 57.14%, significantly higher than that of the control group (32.14%, χ2=3.91, P<0.05). The median survival time of the treatment group was 14.2 months, significantly longer than that of the control group (11.2 months, χ2=2.07,P<0.05). The one-year survival rate of the treatment group was 62.86%, significantly higher than that of the control group (39.29%, χ2=4.40,P<0.05). The incidence rates of side effects of the treatment group were all lower than those of the control group, but there were not significant difference. Conclusions Gensenoside-Rg3 combined with radiotherapy is effective for advanced stage NSCLC, with attenuation and synergistic effects.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9076518  On-line:0

v
Scan QR Code
&et=E0F54BF06C7306DCA0DCBD97F46B1913876310D7F52062021847461546DA8A7E03088A53ED3C88B98C9A53DEA453F0F71827C0E773C836873C56E597F8B13AC79A547CEE4A35143418455AC54BC302853E56B9DD6C5FA8467FED8D4A2BFDFB61F46A651016FA96452DC4EE01A72BA52C&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=99E9153A83D4CB11&aid=C55425D73451440E6BE99AAF42C8981E&vid=&iid=0B39A22176CE99FB&sid=E0F6F365E4766526&eid=FEF02B4635FE8227&fileno=20120222&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="99E9153A83D4CB11"; var my_aid="C55425D73451440E6BE99AAF42C8981E";